For U.S. Residents Only
+|Aa|-

Indication

Renvela® (sevelamer carbonate) is used to control phosphorus levels in adults and children 6 years of age and older with chronic kidney disease (CKD) on dialysis.

Renagel® (sevelamer hydrochloride) is indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis.

Important Safety Information

Do not use Renvela or Renagel if you have a history of bowel obstruction or if you are allergic to sevelamer carbonate or sevelamer hydrochloride or to any of the ingredients in Renvela or Renagel.

Click here for additional Important Safety Information.

Please see Full Prescribing Information for Renvela (PDF) or Full Prescribing Information for Renagel (PDF).

Renassist

Having trouble with Renvela prescription coverage? Renassist® may be able to help. Learn more

Watch this video to see how you can take control of phosphorus.

Renvela® dosage information: 800 mg tablet or 2.4 g powder packet

  • Renvela should be taken:
    • 3 times per day with meals
    • As directed by your doctor
  • Renvela is available in both tablet and powder form:
    • 800 mg tablet
    • 0.8 g and 2.4 g packet of powder

Can I take Renvela with other medicines and/or dietary supplements?

Be sure to tell your doctor about any other medicines and/or dietary supplements you are taking.

What are the common side effects with Renvela?

The most commonly reported side effects with Renvela include vomiting, nausea, diarrhea, indigestion, abdominal pain, flatulence (or excess gas), and constipation. Cases of itching, rash, fecal impaction and, less commonly, slow bowel activity, bowel obstruction, and bowel perforation have been reported. Uncommon cases of difficulty swallowing the Renvela tablet have been reported. Be sure to tell your doctor about any side effects you may be experiencing. Contact your doctor right away if you experience severe abdominal pain, new or worsening constipation, or other severe intestinal symptoms while taking Renvela.

Watch this video to see how you can take control of phosphorus.

English  |  Spanish
English  |  Spanish

Indication

Renvela® (sevelamer carbonate) is used to control phosphorus levels in adults and children 6 years of age and older with chronic kidney disease (CKD) on dialysis.

Renagel® (sevelamer hydrochloride) is indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis.

Important Safety Information

  • Do not use Renvela or Renagel if you have a history of bowel obstruction or if you are allergic to sevelamer carbonate or sevelamer hydrochloride or to any of the ingredients in Renvela or Renagel.
  • Talk to your doctor if you have had difficulty swallowing or swallowing disorders; or if you have had digestive tract surgery or other digestive disorders, including severe constipation.
  • The most common side effects with sevelamer include vomiting, nausea, diarrhea, upset stomach, abdominal pain, flatulence, and constipation.
  • Cases of itching, rash, fecal impaction and, less commonly, slow bowel activity, bowel obstruction, and bowel perforation have been reported.
  • Uncommon cases of difficulty swallowing the Renagel or Renvela tablet have been reported. Talk to your doctor if you have difficulty swallowing medicines in tablet form. Renvela powder for oral suspension may be considered by your doctor if you have a history of difficulty swallowing.
  • Your doctor should monitor bicarbonate and chloride blood levels.
  • Reduced vitamins D, E, and K (clotting factors) and folic acid blood levels may be followed by your doctor.
  • Talk to your doctor when taking sevelamer with other medications.
  • Promptly contact your doctor if you experience severe abdominal pain, new or worsening constipation, or other severe intestinal symptoms while on sevelamer.
  • Take sevelamer with meals and adhere to your prescribed diet

Please see Full Prescribing Information for Renvela (PDF) or Full Prescribing Information for Renagel (PDF).
Click here to learn more about Sanofi's commitment to fighting counterfeit drugs.

The health information contained herein is provided for general education purposes only. Your healthcare professional is the single best source of information regarding your health. Please consult your healthcare professional if you have any questions about your health or treatment.